Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Change in Receivables (2016 - 2025)

Historic Change in Receivables for Prestige Consumer Healthcare (PBH) over the last 16 years, with Q4 2025 value amounting to -$495000.0.

  • Prestige Consumer Healthcare's Change in Receivables fell 10783.6% to -$495000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $27.3 million, marking a year-over-year increase of 38515.0%. This contributed to the annual value of $16.3 million for FY2025, which is 15825.69% up from last year.
  • Per Prestige Consumer Healthcare's latest filing, its Change in Receivables stood at -$495000.0 for Q4 2025, which was down 10783.6% from $29.9 million recorded in Q3 2025.
  • Prestige Consumer Healthcare's Change in Receivables' 5-year high stood at $29.9 million during Q3 2025, with a 5-year trough of -$27.3 million in Q2 2025.
  • Over the past 5 years, Prestige Consumer Healthcare's median Change in Receivables value was $2.0 million (recorded in 2022), while the average stood at $3.7 million.
  • As far as peak fluctuations go, Prestige Consumer Healthcare's Change in Receivables tumbled by 82497.95% in 2024, and later surged by 372604.32% in 2025.
  • Quarter analysis of 5 years shows Prestige Consumer Healthcare's Change in Receivables stood at -$12.5 million in 2021, then soared by 170.56% to $8.8 million in 2022, then grew by 29.88% to $11.4 million in 2023, then tumbled by 44.74% to $6.3 million in 2024, then crashed by 107.84% to -$495000.0 in 2025.
  • Its Change in Receivables stands at -$495000.0 for Q4 2025, versus $29.9 million for Q3 2025 and -$27.3 million for Q2 2025.